Alpha 2.0
Login Register
» Authors » Henk J Aanstoot

Henk J Aanstoot

Explore the profile of Henk J Aanstoot including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 169
Followers 0
Related Specialties
Pediatrics
Endocrinology
General Medicine
Top 10 Co-Authors
Michaela Diamant
Arnoud H de Ru
Peter G F Swift
Tatjana Nikolic
Josine C van der Heyden
Jan Aman
Mark Peakman
Thomas Danne
Maurizio Vanelli
Peter A Van Veelen
Published In
Diabetes Care
Pediatr Diabetes
J Immunol
J Pediatr
Eur J Intern Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR
van Lummel M, Van Veelen P, de Ru A, Janssen G, Pool J, Laban S, et al.
J Immunol . 2016 Mar; 196(8):3253-63. PMID: 26944932
Identifying T cell epitopes of islet autoantigens is important for understanding type 1 diabetes (T1D) immunopathogenesis and to design immune monitoring and intervention strategies in relationship to disease progression. Naturally...
2.
Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule
van Lummel M, Van Veelen P, de Ru A, Pool J, Nikolic T, Laban S, et al.
Diabetes . 2016 Jan; 65(3):732-41. PMID: 26718497
HLA-DQ2/8 heterozygous individuals are at far greater risk for type 1 diabetes (T1D) development by expressing HLA-DQ8trans on antigen-presenting cells compared with HLA-DQ2 or -DQ8 homozygous individuals. Dendritic cells (DC)...
3.
Frequent delay of coeliac disease diagnosis in symptomatic patients with type 1 diabetes mellitus: clinical and genetic characteristics
Bakker S, Tushuizen M, Stokvis-Brantsma W, Aanstoot H, Winterdijk P, van Setten P, et al.
Eur J Intern Med . 2013 Feb; 24(5):456-60. PMID: 23414771
Background: Patients with type 1 diabetes mellitus (T1DM) are more prone to develop other auto-immune diseases, including coeliac disease (CD). Paediatric patients with T1DM are screened for CD, whereas in...
4.
Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009
de Beaufort C, Lange K, Swift P, Aman J, Cameron F, Castano L, et al.
Pediatr Diabetes . 2012 Sep; 14(6):422-8. PMID: 22957743
Objective: To investigate whether center differences in glycemic control are present in prepubertal children <11 yr with type 1 diabetes mellitus. Research Design And Methods: This cross-sectional study involved 18...
5.
Overweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children
van Vliet M, van der Heyden J, Diamant M, von Rosenstiel I, Schindhelm R, Heymans M, et al.
Eur J Pediatr . 2011 Oct; 171(3):493-8. PMID: 21968905
In the present article, we aimed to compare the cardiometabolic risk between overweight children with and without type 1 diabetes (T1DM). Therefore, data with regard to cardiometabolic risk parameters of...
6.
Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk
van Vliet M, van der Heyden J, Diamant M, von Rosenstiel I, Schindhelm R, Aanstoot H, et al.
J Pediatr . 2010 Mar; 156(6):923-929. PMID: 20223481
Objectives: To determine the prevalence of traditional cardiometabolic risk factors and to assess the effect of overweight/obesity on the occurrence of these risk factors in a cohort of children with...
7.
Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes
de Beaufort C, Swift P, Skinner C, Aanstoot H, Aman J, Cameron F, et al.
Diabetes Care . 2007 Jun; 30(9):2245-50. PMID: 17540955
Objective: To reevaluate the persistence and stability of previously observed differences between pediatric diabetes centers and to investigate the influence of demography, language communication problems, and changes in insulin regimens...